Erlotinib (OSI-774, Tarceva™), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Chemotherapy for Advanced Non–Small-Cell Lung Cancer

✍ Scribed by Mary Hightower; Chandra P. Belani; Vinay K. Jain

• Book ID: 114411923
• Publisher: CIG Media Group, LP.
• Year: 2003
• Tongue: English
• Weight: 78 KB
• Volume: 4
• Category: Article
• ISSN: 1525-7304
• DOI: 10.1016/s1525-7304(11)70302-3